Specifications Manual for Joint Commission National Quality Measures (v2019A)

Home » Advanced Certification Heart Failure (ACHF)

Release Notes:
Measure Information Form
Version 2019A


Advanced Certification Heart Failure (ACHF)

Set Measures

Set Measure ID Measure Short Name
ACHF-01 Beta-Blocker Therapy (i.e., Bisoprolol, Carvedilol, or Sustained-Release Metoprolol Succinate Prescribed for LVSD at Discharge)
ACHF-02 Post-Discharge Appointment for Heart Failure Patients
ACHF-03 Care Transition Record Transmitted
ACHF-04 Discussion of Advance Directives/Advance Care Planning
ACHF-05 Advance Directive Executed
ACHF-06 Post-Discharge Evaluation for Heart Failure Patients

General Data Elements

Element Name Collected For
Admission Date All Records,
Birthdate All Records,
Discharge Date All Records, Not collected for HBIPS-2 and HBIPS-3
Hispanic Ethnicity All Records,
ICD-10-CM Principal Diagnosis Code All Records, Optional for HBIPS-2, HBIPS-3
ICD-10-PCS Other Procedure Codes All Records, Optional for All HBIPS Records
ICD-10-PCS Principal Procedure Code All Records, Optional for All HBIPS Records
ICD-10-PCS Principal Procedure Date All Records, Optional for All HBIPS Records
Race All Records,
Sex All Records,

Measure Set Specific Data Elements

Element Name Collected For
Advance Directive Executed ACHF-05
Bisoprolol, Carvedilol, or Sustained-Release Metoprolol Succinate Prescribed for LVSD at Discharge ACHF-01
Care Transition Record Transmitted ACHF-03
Care Transition Record-Discharge Medications ACHF-03
Care Transition Record-Follow-Up Treatment(s) and Service(s) Needed ACHF-03
Care Transition Record-Procedures Performed During Hospitalization ACHF-03
Care Transition Record-Reason for Hospitalization ACHF-03
Care Transition Record-Treatment(s)/Service(s) Provided ACHF-03
Clinical Trial ACHF-01, ACHF-02, ACHF-03, ACHF-06
Comfort Measures Only ACHF
Discharge Disposition ACHF
Discussion of Advance Directives/Advance Care Planning ACHF-04
LVSD < 40% ACHF-01
Post-Discharge Appointment Scheduled Within 7 Days ACHF-02
Post-Discharge Evaluation Conducted Within 72 Hours ACHF-06
Reason for No Bisoprolol, Carvedilol, or Sustained-Release Metoprolol Succinate Prescribed for LVSD at Discharge ACHF-01
Reason for No Post-Discharge Appointment Within 7 Days ACHF-02


  Document Name  
Acknowledgement  
Appendix A - Code Tables  
Appendix C - Medication Tables  
Appendix D - Glossary of Terms  
Appendix E - Overview of Measure Information Form and Flowchart Formats  
Appendix G - Resources  
Appendix H - Miscellaneous Tables  
Cover Page for the Joint Commission Manual  
Data Dictionary  
Introduction to the Manual  
Missing and Invalid Data  
Sampling  
Table of Contents  
Transmission Alpha Data Dictionary  
Transmission Data Processing Flow: Clinical  
Transmission Data Processing Flow: Population and Sampling  
Transmission of Data  
Using the The Joint Commission's National Measure Specifications Manual  

Initial Patient Population Algorithm

ACHF_Init_Pop.jpg

ACHF Sample Size Requirements

Hospitals that choose to sample have the option of sampling quarterly or sampling monthly. A hospital may choose to use a larger sample size than is required. Hospitals whose Initial Patient Population size is less than the minimum number of cases per quarter for the measure set cannot sample.

Regardless of the option used, hospital samples must be monitored to ensure that sampling procedures consistently produce statistically valid and useful data. Due to exclusions, hospitals selecting sample cases MUST submit AT LEAST the minimum required sample size.

The following sample size tables for each option automatically build in the number of cases needed to obtain the required sample sizes. For information concerning how to perform sampling, refer to the Population and Sampling Specifications section in this manual.

Quarterly Sampling

Hospitals performing quarterly sampling for ACHF must ensure that its Initial Patient Population and sample size meet the following conditions:

Quarterly Sample Size
Based on Initial Patient Population Size for the ACHF Measure Set

Hospital's Measure
Average Quarterly
Initial Patient Population
Size “N”
Minimum Required
Sample Size
“n”
≥ 1516 304
381 -— 1515 20% of Initial Patient Population size
76 —- 380 76
0 —- 75 No sampling; 100% Initial Patient Population required

Monthly Sampling

Hospitals performing monthly sampling for ACHF must ensure that its Initial Patient Population and sample size meet the following conditions:

Monthly Sample Size
Based on Initial Patient Population Size for the ACHF Measure Set

Hospital's Measure
Average Monthly
Initial Patient Population
Size “N”
Minimum Required
Sample Size
“n”
≥ 506 102
131 -— 505 20% of Initial Patient Population size
26 -— 130 26
<26 No sampling; 100% Initial Patient Population required

Sample Size Examples

  • Quarterly sampling:
    • The ACHF Initial Patient Population size for a hospital has been 500 patients per quarter during the past year. The required quarterly sample size would be 100 (twenty percent of 500) heart failure patients per quarter -- as this number is smaller than the maximum condition (i.e., 304 cases) and larger than the minimum condition (i.e., 76 cases).
    • A hospital's ACHF Initial Patient Population size is 1,482 patients during the third quarter. The required sample size is 20% of the patient population or 297 cases for the quarter (twenty percent of 1,482 equals 296.4 rounded to the next highest whole number equals 297).

  • Monthly sampling:
    • A hospital's ACHF Initial Patient Population size is 25 patients during March. Since this is less than the minimum condition (i.e., 26 cases), no sampling is allowed or 100% of the patient population of 25 cases is required.
    • A hospital's ACHF Initial Patient Population size is 503 patients during July. The required sample size is 20% of the patient population or 101 cases for the month (twenty percent of 503 equals 100.6 rounded to the next highest whole number equals 101).


Measure Information Form ACHF
CPT® only copyright 2019 American Medical Association. All rights reserved.
Specifications Manual for Joint Commission National Quality Measures (v2019A)
Discharges 07-01-19 (3Q19) through 12-31-19 (4Q19)

LICENSE FOR USE OF CURRENT PROCEDURAL TERMINOLOGY, FOURTH EDITION (“CPT®”)

CPT® only copyright 2019 American Medical Association. All rights reserved. CPT® is a registered trademark of the American Medical Association.

You, your employees and agents are authorized to use CPT® only as contained in The Joint Commission performance measures solely for your own personal use in directly participating in healthcare programs administered by The Joint Commission. You acknowledge that the American Medical Association (“AMA”) holds all copyright, trademark and other rights in CPT®.

Any use not authorized herein is prohibited, including by way of illustration and not by way of limitation, making copies of CPT® for resale and/or license, transferring copies of CPT® to any party not bound by this Agreement, creating any modified or derivative work of CPT®, or making any commercial use of CPT®. License to use CPT® for any use not authorized herein must be obtained through the American Medical Association, Intellectual Property Services, AMA Plaza, 330 North Wabash Avenue, Suite 39300, Chicago, Illinois 60611-5885. Applications are available at the American Medical Association Web site, www.ama- assn.org/go/cpt.

U.S. Government Rights This product includes CPT® which is commercial technical data, which was developed exclusively at private expense by the American Medical Association, 330 North Wabash Avenue, Chicago, Illinois 60611. The American Medical Association does not agree to license CPT® to the Federal Government based on the license in FAR 52.227-14 (Data Rights - General) and DFARS 252.227-7015 (Technical Data - Commercial Items) or any other license provision. The American Medical Association reserves all rights to approve any license with any Federal agency.

Disclaimer of Warranties and Liabilities. CPT® is provided “as is” without warranty of any kind, either expressed or implied, including but not limited to the implied warranties of merchantability and fitness for a particular purpose. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT®, and the (AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The responsibility for the content of this product is with The Joint Commission, and no endorsement by the AMA is intended or implied. The AMA disclaims responsibility for any consequences or liability attributable to or related to any use, non-use, or interpretation of information contained or not contained in this product.

This Agreement will terminate upon notice if you violate its terms. The AMA is a third party beneficiary to this Agreement.

Should the foregoing terms and conditions be acceptable to you, please indicate your agreement and acceptance by clicking below on the button labeled “accept”.

^